All Stories

  1. Blood-brain Barrier Dysfunction and Extension of Time Window for Thrombolysis: A Limitation not Evaluated

    Article • Current Vascular Pharmacology, November 2021, Bentham Science Publishers

    Dr Antonio Siniscalchi, Dr Luca Gallelli

  2. Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity

    Article • Current Medicinal Chemistry, March 2020, Bentham Science Publishers

    Dr Luca Gallelli, Maria De Rosa, Ankur Pandey

  3. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties

    Article • Drug Design Development and Therapy, September 2019, Taylor & Francis

    Dr Luca Gallelli

  4. What is the Current Role for Vitamin D and the Risk of Stroke?

    Article • Current Neurovascular Research, July 2019, Bentham Science Publishers

    Dr Antonio Siniscalchi, Piergiorgio Lochner, Dr Luca Gallelli

  5. Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report

    Article • Current Drug Safety, May 2019, Bentham Science Publishers

    Professor Giovambattista De Sarro, Dr Luca Gallelli

  6. miRNA and ketogenic diet, what's the link and what's the inpact on it

    Article • MicroRNA, February 2019, Bentham Science Publishers

    dr Roberto Cannataro, Dr Luca Gallelli, Professor Giovambattista De Sarro, Dr Mariarita Perri

  7. Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome

    Article • International Medical Case Reports Journal, February 2019, Dove Medical Press

    Prof Domenico Chirchiglia , Rosa Marotta, Dr Luca Gallelli

  8. Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation

    Article • Current Drug Safety, January 2019, Bentham Science Publishers

    Professor Giovambattista De Sarro, Dr Luca Gallelli

  9. Variation in Immune-Related microRNAs Profile in Human Milk Amongst Lactating Women

    Article • MicroRNA, June 2018, Bentham Science Publishers

    Dr Mariarita Perri, dr Roberto Cannataro, Dr Luca Gallelli, Professor Giovambattista De Sarro

  10. Drug-Drug Interactions in Cocaine-users and their Clinical Implications

    Article • Current Drug Abuse Reviews, June 2018, Bentham Science Publishers

    Dr Luca Gallelli, Dr Antonio Siniscalchi, Professor Giovambattista De Sarro

  11. Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice

    Article • The Journal of Clinical Pharmacology, May 2018, Wiley

    Professor Giovambattista De Sarro, Dr Luca Gallelli

  12. Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?

    Article • Current Drug Safety, March 2018, Bentham Science Publishers

    Dr Luca Gallelli

  13. N-Palmitoyl Ethanol Amide Pharmacological Treatment in Patients With Nonsurgical Lumbar Radiculopathy

    Article • The Journal of Clinical Pharmacology, January 2018, Wiley

    Dr Luca Gallelli

  14. microRNAs to Monitor Pain-migraine and Drug Treatment

    Article • MicroRNA, December 2017, Bentham Science Publishers

    Dr Antonio Siniscalchi, Dr Luca Gallelli

  15. Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients

    Article • Current Drug Safety, October 2017, Bentham Science Publishers

    Dr Antonio Siniscalchi, Dr Luca Gallelli, laura mumoli

  16. Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

    Article • Drug Design Development and Therapy, October 2017, Dove Medical Press

    Maria Teresa Busceti, Dr Luca Gallelli, Corrado Pelaia

  17. theophylline affect human bronchial epithelial cells

    Article • Drug Design Development and Therapy, January 2017, Dove Medical Press

    Dr Luca Gallelli, Dr Mariarita Perri, dr Roberto Cannataro, Giuseppe Spaziano, Prof. Ph.D Giuseppe Spaziano

  18. nutraceutical drug interaction

    Article • Current Drug Safety, September 2016, Bentham Science Publishers

    Dr Luca Gallelli, dr Roberto Cannataro

  19. Role of biologics in severe eosinophilic asthma – focus on reslizumab

    Article • Therapeutics and Clinical Risk Management, July 2016, Dove Medical Press

    Dr Luca Gallelli, Maria Teresa Busceti

  20. Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

    Article • Drug Design Development and Therapy, June 2016, Dove Medical Press

    Dr Luca Gallelli, Professor Bruno Amato

  21. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

    Article • Therapeutics and Clinical Risk Management, October 2015, Dove Medical Press

    Dr Luca Gallelli, Maria Teresa Busceti, Cecilia Calabrese

  22. The use of growth factors, CD34+cells and fibrin for the management of chronic venous ulcers

    Article • International Wound Journal, September 2015, Wiley

    Dr Luca Gallelli

  23. Aterofisiol® in carotid plaque evolution

    Article • Drug Design Development and Therapy, July 2015, Dove Medical Press

    Dr Luca Gallelli, Professor Bruno Amato

  24. Recurrence of atrial fibrillation after switching from brand to generic atenolol

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2015, Medknow

    Dr Luca Gallelli

  25. The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs

    Article • Drug Design Development and Therapy, May 2014, Taylor & Francis

    Professor Bruno Amato, Dr Luca Gallelli, Giuseppe Spaziano, Prof. Ph.D Giuseppe Spaziano

  26. Skin rash during treatment with generic itraconazole

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2014, Medknow

    Dr Luca Gallelli

  27. Effects of Acetaminophen and Ibuprofen in Children With Migraine Receiving Preventive Treatment With Magnesium

    Article • Headache The Journal of Head and Face Pain, June 2013, Wiley

    Dr Luca Gallelli